about
Comparative in vitro and in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations.Characterization of an Italian founder mutation in the RING-finger domain of BRCA1.Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interactionFANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorThe BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and SpainUnclassified variants in BRCA genes: guidelines for interpretationThe FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancerCirculating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk
P50
Q34603197-92038351-1FFA-4210-B1EA-47E4921246D7Q35091400-24A6149C-05B2-411D-864A-902FD5FB6A97Q35679203-B68A0515-32BC-460D-843C-174117D2628EQ35999309-1825EF46-C24B-4498-8427-7A16ED1844BFQ49817640-673EADA9-A5FF-4638-8A3B-2540FDDA2672Q57265670-6C3DE032-BA2E-4702-9DA8-F23369578E11Q60170551-81533557-F4E8-4BA8-B72F-3E5ED949B66CQ91178389-22D17AE9-3CCE-4686-A9DC-5D5E5558E8F0Q93063421-164BFEA0-1972-425C-BE79-B901429143A1
P50
description
forsker
@nb
researcher ORCID ID = 0000-0002-3381-7493
@en
wetenschapper
@nl
name
L. Caleca
@ast
L. Caleca
@nl
Laura Caleca
@en
Laura Caleca
@es
Laura Caleca
@nb
type
label
L. Caleca
@ast
L. Caleca
@nl
Laura Caleca
@en
Laura Caleca
@es
Laura Caleca
@nb
altLabel
L. Caleca
@en
prefLabel
L. Caleca
@ast
L. Caleca
@nl
Laura Caleca
@en
Laura Caleca
@es
Laura Caleca
@nb
P106
P1153
23972166800
P31
P496
0000-0002-3381-7493